Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Ascendis Pharma Secures $150M Royalty Deal

Royalty Pharma invests $150 million in Ascendis Pharma in exchange for a 9.15% royalty on Skytrofa's U.S. revenues

Ascendis Pharma Logo
Ascendis

According to a recent FiercePharma article, Ascendis Pharma has received a $150M investment from Royalty Pharma. In return, Royalty Pharma will get a 9.15% royalty on Skytrofa sales in the United States in 2025. This cash will help Ascendis lower its costs and deliver medicines to patients faster. Skytrofa is the first drug of its kind and only needs to be taken once a week, unlike the daily alternatives. It made about $39M in 2022, and is on track to outpace those sales this year.

Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO